ExThera Medical develops extracorporeal blood filtration devices, including theSeraph®100 Microbind®Affinity Blood Filter,and ONCObind™Blood Filter for removing harmful substances from the bloodstream of patients. ExThera Medical’s extracorporeal products are in development for patients suffering from severe infections. Products are also being developed for the treatment of metastatic cancer.
| Website | http://www.extheramedical.com |
| Revenue | $6.8 million |
| Employees | 38 (38 on RocketReach) |
| Founded | 2007 |
| Address | 757 Arnold Drive Suite B, Martinez, California 94553, US |
| Industry | Medical Devices |
| Keywords | Pathogen Reduction, Sepsis Treatment, Medical Devices, Blood Purification, Infection Control, Infectious Disease, Medical Technology, Therapeutic Devices, Critical Care, Immunotherapy, Healthcare Technology, Biomedical Engineering, Life Support, Point Of Care |
| Competitors | Boston Scientific, Baxter International Inc., Medtronic, Abbott, AngioDynamics, Cleveland Clinic, Cordis, Terumo Heart, Inc., HemaCare Corporation, 旭化成ホームズ(株) +39 more (view full list) |
Looking for a particular ExThera Medical employee's phone or email?
The ExThera Medical annual revenue was $6.8 million in 2026.
Erin Borger is the CEO of ExThera Medical.
38 people are employed at ExThera Medical.
ExThera Medical is based in Martinez, California.